Skip to menu Skip to content Skip to footer
Dr Mark Effron
Dr

Mark Effron

Email: 

Overview

Availability

Dr Mark Effron is:
Available for supervision

Works

Search Professor Mark Effron’s works on UQ eSpace

169 works between 1978 and 2025

81 - 100 of 169 works

2013

Journal Article

Effect on platelet reactivity from a prasugrel loading dose after a clopidogrel loading dose compared with a prasugrel loading dose alone: Transferring From Clopidogrel Loading Dose to Prasugrel Loading Dose in Acute Coronary Syndrome Patients (TRIPLET): a randomized controlled trial

Diodati, Jean G., Saucedo, Jorge F., French, John K., Fung, Anthony Y., Cardillo, Tracy E., Henneges, Carsten, Effron, Mark B., Fisher, Harold N. and Angiolillo, Dominick J. (2013). Effect on platelet reactivity from a prasugrel loading dose after a clopidogrel loading dose compared with a prasugrel loading dose alone: Transferring From Clopidogrel Loading Dose to Prasugrel Loading Dose in Acute Coronary Syndrome Patients (TRIPLET): a randomized controlled trial. Circulation-Cardiovascular Interventions, 6 (5), 567-574. doi: 10.1161/CIRCINTERVENTIONS.112.000063

Effect on platelet reactivity from a prasugrel loading dose after a clopidogrel loading dose compared with a prasugrel loading dose alone: Transferring From Clopidogrel Loading Dose to Prasugrel Loading Dose in Acute Coronary Syndrome Patients (TRIPLET): a randomized controlled trial

2013

Journal Article

Enhanced active metabolite generation and platelet inhibition with prasugrel compared to clopidogrel regardless of genotype in thienopyridine metabolic pathways

Braun, Oscar O., Angiolillo, Dominick J., Ferreiro, Jose L., Jakubowski, Joseph A., Winters, Kenneth J., Effron, Mark B., Duvvuru, Suman, Costigan, Timothy M., Sundseth, Scott S., Walker, Joseph R., Saucedo, Jorge F., Kleiman, Neal S. and Varenhorst, Christoph (2013). Enhanced active metabolite generation and platelet inhibition with prasugrel compared to clopidogrel regardless of genotype in thienopyridine metabolic pathways. Thrombosis and Haemostasis, 110 (6), 1223-1231. doi: 10.1160/TH13-03-0263

Enhanced active metabolite generation and platelet inhibition with prasugrel compared to clopidogrel regardless of genotype in thienopyridine metabolic pathways

2013

Conference Publication

Contemporary use of platelet function and pharmacogenomic testing among acute myocardial infarction patients treated with PCI in the United States: insights from the TRANSLATE-ACS study

Wang, T. Y., Henry, T. D., Mccoy, L. A., Berger, P. B., Cohen, D. J., Effron, M. B., Zettler, M., Vaitkus, P. T., Messenger, J. C. and Peterson, E. D. (2013). Contemporary use of platelet function and pharmacogenomic testing among acute myocardial infarction patients treated with PCI in the United States: insights from the TRANSLATE-ACS study. Congress of the European-Society-of-Cardiology (ESC), Amsterdam Netherlands, Aug 31-Sep 04, 2013. OXFORD: OXFORD UNIV PRESS.

Contemporary use of platelet function and pharmacogenomic testing among acute myocardial infarction patients treated with PCI in the United States: insights from the TRANSLATE-ACS study

2013

Journal Article

Adherence and persistence with prasugrel following acute coronary syndrome with percutaneous coronary intervention

Nordstrom, Beth L., Simeone, Jason C., Zhao, Zhenxiang, Molife, Cliff, McCollam, Patrick L., Ye, Xin and Effron, Mark B. (2013). Adherence and persistence with prasugrel following acute coronary syndrome with percutaneous coronary intervention. American Journal of Cardiovascular Drugs, 13 (4), 263-271. doi: 10.1007/s40256-013-0028-1

Adherence and persistence with prasugrel following acute coronary syndrome with percutaneous coronary intervention

2013

Conference Publication

THE ASSOCIATION OF DISCHARGE ASPIRIN DOSE AND OUTCOMES IN ACUTE MYOCARDIAL INFARCTION: INSIGHTS FROM THE TRANSLATE-ACS STUDY

Xian, Ying, Wang, Tracy, Kaltenbach, Lisa, Effron, Mark, Henry, Timothy, Bach, Richard, Zettler, Marjorie, Vaitkus, Paul, Fonarow, Gregg and Peterson, Eric (2013). THE ASSOCIATION OF DISCHARGE ASPIRIN DOSE AND OUTCOMES IN ACUTE MYOCARDIAL INFARCTION: INSIGHTS FROM THE TRANSLATE-ACS STUDY. 62nd Annual Scientific Session of the American-College-of-Cardiology, San Francisco Ca, Mar 09-11, 2013. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/S0735-1097(13)60112-6

THE ASSOCIATION OF DISCHARGE ASPIRIN DOSE AND OUTCOMES IN ACUTE MYOCARDIAL INFARCTION: INSIGHTS FROM THE TRANSLATE-ACS STUDY

2013

Conference Publication

EARLY CESSATION OF ADP RECEPTOR INHIBITORS AMONG ACUTE MYOCARDIAL INFARCTION PATIENTS TREATED WITH PCI: INSIGHTS FROM THE TRANSLATE-ACS STUDY

Fosbol, Emil L., Peterson, Eric, Honeycutt, Emily, Zettler, Marjorie, Messenger, John, Waksman, Ron, Effron, Mark, Vaitkus, Paul, Cohen, David and Wang, Tracy (2013). EARLY CESSATION OF ADP RECEPTOR INHIBITORS AMONG ACUTE MYOCARDIAL INFARCTION PATIENTS TREATED WITH PCI: INSIGHTS FROM THE TRANSLATE-ACS STUDY. 62nd Annual Scientific Session of the American-College-of-Cardiology, San Francisco Ca, Mar 09-11, 2013. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/S0735-1097(13)61592-2

EARLY CESSATION OF ADP RECEPTOR INHIBITORS AMONG ACUTE MYOCARDIAL INFARCTION PATIENTS TREATED WITH PCI: INSIGHTS FROM THE TRANSLATE-ACS STUDY

2013

Journal Article

TransRadial Education And Therapeutics (TREAT): shifting the balance of safety and efficacy of antithrombotic agents in percutaneous coronary intervention: a report from the Cardiac Safety Research Consortium

Hess, Connie N., Rao, Sunil V., Kong, David F., Miller, Julie M., Anstrom, Kevin J., Bertrand, Olivier F., Collet, Jean-Philippe, Effron, Mark B., Eloff, Benjamin C., Fadiran, Emmanuel O., Farb, Andrew, Gilchrist, Ian C., Holmes, David R., Jacobs, Alice K., Kaul, Prashant, Newby, L. Kristin, Rutledge, David R., Tavris, Dale R., Tsai, Thomas T., White, Roseann M., Peterson, Eric D. and Krucoff, Mitchell W. (2013). TransRadial Education And Therapeutics (TREAT): shifting the balance of safety and efficacy of antithrombotic agents in percutaneous coronary intervention: a report from the Cardiac Safety Research Consortium. American Heart Journal, 165 (3), 344-353.e1. doi: 10.1016/j.ahj.2012.09.008

TransRadial Education And Therapeutics (TREAT): shifting the balance of safety and efficacy of antithrombotic agents in percutaneous coronary intervention: a report from the Cardiac Safety Research Consortium

2013

Journal Article

Decrease in high on-treatment platelet reactivity (HPR) prevalence on switching from clopidogrel to prasugrel: insights from the switching anti-platelet (SWAP) study

Saucedo, Jorge F., Angiolillo, Dominick J., DeRaad, Roger, Frelinger, Andrew L., Gurbel, Paul A., Costigan, Timothy M., Jakubowski, Joseph A., Ojeh, Clement K., Duvvuru, Suman and Effron, Mark B. (2013). Decrease in high on-treatment platelet reactivity (HPR) prevalence on switching from clopidogrel to prasugrel: insights from the switching anti-platelet (SWAP) study. Thrombosis and Haemostasis, 109 (2), 347-355. doi: 10.1160/TH12-06-0378

Decrease in high on-treatment platelet reactivity (HPR) prevalence on switching from clopidogrel to prasugrel: insights from the switching anti-platelet (SWAP) study

2012

Conference Publication

Unplanned 30-Day Readmission Risk Among Patients with Acute Myocardial Infarction: A Report from TRANSLATE-ACS

Hess, Connie N., Wang, Tracy Y., Kaltenbach, Lisa, Honeycutt, Emily, Messenger, John C., Smith, William T., Zettler, Marjorie E., Effron, Mark B., Henry, Timothy D., Peterson, Eric D. and Fonarow, Gregg C. (2012). Unplanned 30-Day Readmission Risk Among Patients with Acute Myocardial Infarction: A Report from TRANSLATE-ACS. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

Unplanned 30-Day Readmission Risk Among Patients with Acute Myocardial Infarction: A Report from TRANSLATE-ACS

2012

Conference Publication

Transferring from Clopidogrel Loading Dose to Prasugrel Loading Dose in Acute Coronary Syndrome Patients: High on-Treatment Platelet Reactivity Analysis of the TRIPLET Trial

Diodati, Jean, Angiolillo, Dominick, Saucedo, Jorge, Cardillo, Tracy, Jakubowski, Joseph, Henneges, Carsten, Effron, Mark, Lipkin, Fred and Fisher, Harold (2012). Transferring from Clopidogrel Loading Dose to Prasugrel Loading Dose in Acute Coronary Syndrome Patients: High on-Treatment Platelet Reactivity Analysis of the TRIPLET Trial. Transcatheter Cardiovascular Therapeutics (TCT) Symposium, Miami Fl, Oct 22-26, 2012. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/j.jacc.2012.08.764

Transferring from Clopidogrel Loading Dose to Prasugrel Loading Dose in Acute Coronary Syndrome Patients: High on-Treatment Platelet Reactivity Analysis of the TRIPLET Trial

2012

Conference Publication

TRANSFERRING FROM CLOPIDOGREL LOADING DOSE TO PRASUGREL LOADING DOSE IN ACUTE CORONARY SYNDROME PATIENTS: THE TRIPLET TRIAL

Diodati, J. G., Fung, A., Saucedo, J. F., Oguzhan, A., Gaxiola, E., Cardillo, T. E., Effron, M. B., Fisher, H. N., Henneges, C. and Angiolillo, D. J. (2012). TRANSFERRING FROM CLOPIDOGREL LOADING DOSE TO PRASUGREL LOADING DOSE IN ACUTE CORONARY SYNDROME PATIENTS: THE TRIPLET TRIAL. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/j.cjca.2012.07.655

TRANSFERRING FROM CLOPIDOGREL LOADING DOSE TO PRASUGREL LOADING DOSE IN ACUTE CORONARY SYNDROME PATIENTS: THE TRIPLET TRIAL

2012

Conference Publication

CHARACTERISTICS OF PATIENTS TREATED WITH THIENOPYRIDINES FOLLOWING ACS-PCI

Nordstrom, B., Simeone, J. C., Zhao, Z., Molife, C., Mccollam, P. L., Ye, X. and Effron, M. B. (2012). CHARACTERISTICS OF PATIENTS TREATED WITH THIENOPYRIDINES FOLLOWING ACS-PCI. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/j.jval.2012.03.721

CHARACTERISTICS OF PATIENTS TREATED WITH THIENOPYRIDINES FOLLOWING ACS-PCI

2012

Conference Publication

MEDICATION ADHERENCE AND PERSISTENCE OF PRASUGREL INITIATORS POST ACS-PCI

Simeone, J. C., Nordstrom, B., Zhao, Z., Molife, C., Mccollam, P. L., Ye, X. and Effron, M. B. (2012). MEDICATION ADHERENCE AND PERSISTENCE OF PRASUGREL INITIATORS POST ACS-PCI. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/j.jval.2012.03.047

MEDICATION ADHERENCE AND PERSISTENCE OF PRASUGREL INITIATORS POST ACS-PCI

2012

Conference Publication

MEDICATION NONADHERENCE AMONG PATIENTS WITH ACUTE MYOCARDIAL INFARCTION TREATED WITH PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE TRANSLATE-ACS STUDY

Mathews, Robin, Peterson, Eric, Honeycutt, Emily, Chin, Chee Tang, Ryan, Kelley, Effron, Mark, Zettler, Marjorie, Rozek, Maurice, Henry, Timothy and Wang, Tracy (2012). MEDICATION NONADHERENCE AMONG PATIENTS WITH ACUTE MYOCARDIAL INFARCTION TREATED WITH PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE TRANSLATE-ACS STUDY. 61st Annual Scientific Session and Expo of the American-College-of-Cardiology (ACC), Chicago Il, Mar 24-27, 2012. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/S0735-1097(12)61815-4

MEDICATION NONADHERENCE AMONG PATIENTS WITH ACUTE MYOCARDIAL INFARCTION TREATED WITH PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE TRANSLATE-ACS STUDY

2011

Conference Publication

Post-discharge Bleeding and Thienopyridine Discontinuation among AMI Patients Treated with PCI: Insights from the TRANSLATE-ACS Study

Wang, Tracy Y., Honeycutt, Emily, Henry, Timothy D., Effron, Mark B., Messenger, John C., Cohen, David J., Mark, Daniel B., Stone, Gregg W., Singh, Mandeep, Rozek, Maurice, Fonarow, Gregg C. and Peterson, Eric D. (2011). Post-discharge Bleeding and Thienopyridine Discontinuation among AMI Patients Treated with PCI: Insights from the TRANSLATE-ACS Study. 23rd Annual Transcatheter Cardiovascular Therapeutics (TCT) Symposium, San Francisco Ca, Nov 07-11, 2011. NEW YORK: ELSEVIER SCIENCE INC.

Post-discharge Bleeding and Thienopyridine Discontinuation among AMI Patients Treated with PCI: Insights from the TRANSLATE-ACS Study

2011

Journal Article

Treatment with adenosine diphosphate receptor inhibitors-longitudinal assessment of treatment patterns and events after acute coronary syndrome (TRANSLATE-ACS) study design: expanding the paradigm of longitudinal observational research

Chin, Chee Tang, Wang, Tracy Y., Anstrom, Kevin J., Zhu, Baojin, Maa, Jen-Fue, Messenger, John C., Ryan, Kelley A., Davidson-Ray, Linda, Zettler, Marjorie, Effron, Mark B., Mark, Daniel B. and Peterson, Eric D. (2011). Treatment with adenosine diphosphate receptor inhibitors-longitudinal assessment of treatment patterns and events after acute coronary syndrome (TRANSLATE-ACS) study design: expanding the paradigm of longitudinal observational research. American Heart Journal, 162 (5), 844-851. doi: 10.1016/j.ahj.2011.08.021

Treatment with adenosine diphosphate receptor inhibitors-longitudinal assessment of treatment patterns and events after acute coronary syndrome (TRANSLATE-ACS) study design: expanding the paradigm of longitudinal observational research

2011

Journal Article

A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 Trial

Angiolillo, Dominick J., JoseBadimon, Juan, Saucedo, Jorge F., Frelinger, Andrew L., Michelson, Alan D., Jakubowski, Joseph A., Zhu, Baojin, Ojeh, Clement K., Baker, Brian A. and Effron, Mark B. (2011). A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 Trial. European Heart Journal, 32 (7), 838-846. doi: 10.1093/eurheartj/ehq494

A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 Trial

2011

Journal Article

The onset of inhibition of platelet aggregation with prasugrel compared with clopidogrel loading doses using gatekeeping analysis of integrated clinical pharmacology data

Zhu, Baojin, Effron, Mark B., Kulkarni, Pandurang M., Li, Ying G., Jakubowski, Joseph A., Miller, Debra L., Baker, Brian A., Luo, Junxiang, Small, David S. and Winters, Kenneth J. (2011). The onset of inhibition of platelet aggregation with prasugrel compared with clopidogrel loading doses using gatekeeping analysis of integrated clinical pharmacology data. Journal of Cardiovascular Pharmacology, 57 (3), 317-324. doi: 10.1097/FJC.0b013e3182073dfb

The onset of inhibition of platelet aggregation with prasugrel compared with clopidogrel loading doses using gatekeeping analysis of integrated clinical pharmacology data

2010

Journal Article

Increased Platelet Inhibition After Switching From Maintenance Clopidogrel to Prasugrel in Patients With Acute Coronary Syndromes Results of the SWAP (SWitching Anti Platelet) Study

Angiolillo, Dominick J., Saucedo, Jorge F., DeRaad, Roger, Frelinger, Andrew L., Gurbel, Paul A., Costigan, Timothy M., Jakubowski, Joseph A., Ojeh, Clement K. and Effron, Mark B. (2010). Increased Platelet Inhibition After Switching From Maintenance Clopidogrel to Prasugrel in Patients With Acute Coronary Syndromes Results of the SWAP (SWitching Anti Platelet) Study. Journal of the American College of Cardiology, 56 (13), 1017-1023. doi: 10.1016/j.jacc.2010.02.072

Increased Platelet Inhibition After Switching From Maintenance Clopidogrel to Prasugrel in Patients With Acute Coronary Syndromes Results of the SWAP (SWitching Anti Platelet) Study

2010

Conference Publication

Lack of rebound in platelet reactivity following cessation of prasugrel or clopidogrel in type 2 diabetes mellitus patients with coronary artery disease: insights from OPTIMUS-3

Angiolillo, D. J., Jakubowski, J. A., Frelinger, M. U., Zafar, M. U., Saucedo, J. F., Michelson, A. D., Zhu, B., Ojeh, C. K., Baker, B. A. and Effron, M. B. (2010). Lack of rebound in platelet reactivity following cessation of prasugrel or clopidogrel in type 2 diabetes mellitus patients with coronary artery disease: insights from OPTIMUS-3. ESC Congress, Stockholm Sweden, Aug 28-Sep 01, 2010. OXFORD: OXFORD UNIV PRESS.

Lack of rebound in platelet reactivity following cessation of prasugrel or clopidogrel in type 2 diabetes mellitus patients with coronary artery disease: insights from OPTIMUS-3

Supervision

Availability

Dr Mark Effron is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Media

Enquiries

For media enquiries about Dr Mark Effron's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au